Systematic review: the association between the gut microbiota and medical therapies in inflammatory bowel disease

Summary Background The gut microbiota has been implicated in the pathogenesis of inflammatory bowel disease (IBD), with Faecalibacterium prausnitizii associated with protection, and certain genera (including Shigella and Escherichia) associated with adverse features. The variability of patient respo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 2022-01, Vol.55 (1), p.26-48
Hauptverfasser:	Radhakrishnan, Shiva T., Alexander, James L., Mullish, Benjamin H., Gallagher, Kate I., Powell, Nick, Hicks, Lucy C., Hart, Ailsa L., Li, Jia V., Marchesi, Julian R., Williams, Horace R. T.
Format:	Artikel
Sprache:	eng
Schlagworte:	Escherichia Faecalibacterium Gastrointestinal Microbiome Genera Humans Inflammatory bowel disease Inflammatory bowel diseases Inflammatory Bowel Diseases - drug therapy Infliximab Intestinal microflora Intestine Microbiota Monoclonal antibodies Mucosa Patients Phenotypes Tumor Necrosis Factor Inhibitors Tumor necrosis factor-α
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!